SPONSOR
Nantes University Hospital
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic LeukemiaHCC - Hepatocellular CarcinomaMultiple Sclerosis
Nantes University Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, HCC - Hepatocellular Carcinoma.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nantes University Hospital
How many clinical trials has Nantes University Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Nantes University Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nantes University Hospital research focus on?
Nantes University Hospital clinical trials span Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, HCC - Hepatocellular Carcinoma, Multiple Sclerosis. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Nantes University Hospital clinical trial?
To participate in a Nantes University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nantes University Hospital trials with current recruitment status updated daily.
Clinical Trials by Nantes University Hospital
NCT06439199
Recruiting
Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
Acute Myeloid Leukemia
NCT06999837
Recruiting
[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.
HCC - Hepatocellular Carcinoma
NCT04873492
Recruiting
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
Multiple Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology